Related content

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer

By Lipton Allan   Goodman Laurie   Leitzel Kim   Cook Jennifer   Sperinde Jeff   Haddad Mojgan   Köstler Wolfgang   Huang Weidong   Weidler Jodi   Ali Suhail   Newton Alicia   Fuchs Eva-Marie   Paquet Agnes   Singer Christian   Horvat Reinhard   Jin Xueguang   Banerjee Joyee   Mukherjee Ali   Tan Yuping   Shi Yining   Chenna Ahmed   Larson Jeff   Lie Yolanda   Sherwood Thomas   Petropoulos Christos   Williams Stephen   Winslow John   Parry Gordon   Bates Michael  

Breast Cancer Research and Treatment, Vol. 141, Iss. 1, 2013-08 ,pp. : 43-53

Springer Publishing Company

Access to resources Recommend Favorite

A clinicalbiological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status

By Bria E.   De Manzoni G.   Beghelli S.   Tomezzoli A.   Barbi S.   Di Gregorio C.   Scardoni M.   Amato E.   Frizziero M.   Sperduti I.   Corbo V.   Brunelli M.   Bersani S.   Tortora G.   Scarpa A.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 693-701

Oxford University Press

Access to resources Recommend Favorite

Promoter methylation status of the FHIT gene and Fhit expression: Association with HER2/neu status in breast cancer patients

By            

Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. : 2270-2278

Spandidos Publications

Access to resources Recommend Favorite

[Erratum] HER 2/neu protein expression in gastric cancer is associated with poor survival

By            

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 4794-4794

Spandidos Publications

Access to resources Recommend Favorite

Her-2/ neu Gene Amplification and Protein Expression in Primary Male Breast Cancer

By Rudlowski Christian  

Breast Cancer Research and Treatment, Vol. 84, Iss. 3, 2004-04 ,pp. : 215-223

Springer Publishing Company

Access to resources Recommend Favorite